TG Therapeutics (TGTX) Tops Q3 EPS by 70c

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of $0.73, $0.70 better than the analyst estimate of $0.03. Revenue for the quarter came in at $165.82 million versus the consensus estimate of $24.75 million.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Jefferies Reinstates Talen Energy (TLN) at Hold